| CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. | |
| | |
MedLine Citation:
|
PMID: 12384915 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: CD14+,CD16+ monocytes, identified as a minor population of monocytes in human peripheral blood (PB), have been implicated in several inflammatory diseases. We undertook this study to investigate the relevance of this phenotype to joint inflammation in rheumatoid arthritis (RA). METHODS: The expression of CD14, CD16, CC chemokine receptor 1 (CCR1), CCR5, and intercellular adhesion molecule 1 (ICAM-1) on monocytes was measured by flow cytometric analysis. Concentrations of the cytokines known to induce CD16 (including transforming growth factor beta1 [TGFbeta1], macrophage colony-stimulating factor [M-CSF], and interleukin-10 [IL-10]) and concentrations of the soluble form of CD14 (sCD14) in plasma and synovial fluid (SF) samples were measured by enzyme-linked immunosorbent assay. The induction of CD16 on RA blood monocytes cultured for 18 hours with 1 or with all 3 cytokines was determined. RESULTS: The mean +/- SD frequency of CD14+,CD16+ blood monocytes was significantly increased in RA patients (11.7 +/- 5.6%; n = 105) compared with healthy controls (9.5 +/- 2.2%; n = 15) (P < 0.01), and the patient group with an increased frequency of CD16+ monocytes (> or =13.9%) had active disease, as defined by increased counts of tender and swollen joints, levels of acute-phase reactants, and titers of rheumatoid factor. The response to drug therapy correlated with changes in the frequency of this phenotype. The expression of CD16 on SF monocytes from RA patients was markedly elevated compared with the expression on PB monocytes. CD16 expression on RA blood monocytes was augmented in vitro by IL-10, M-CSF, and TGFbeta1. Plasma concentrations of these cytokines and of sCD14 were significantly higher in RA patients with high CD16+ monocyte frequencies than in those with low CD16+ monocyte frequencies or in healthy controls. CD14+,CD16+ monocytes expressed higher levels of CCR1, CCR5, and ICAM-1 than did regular CD14++,CD16- monocytes, particularly in active RA. CONCLUSION: These results indicate that the maturation of blood monocytes into tissue-infiltrative CD16+ cells before entry into the joint, induced by cytokine spillover from the inflamed joint, may contribute to the persistent joint inflammation of RA. |
| | |
Authors:
|
Norikuni Kawanaka; Masahiro Yamamura; Tetsushi Aita; Yoshitaka Morita; Akira Okamoto; Masanori Kawashima; Mitsuhiro Iwahashi; Akiko Ueno; Yasukazu Ohmoto; Hirofumi Makino |
Related Documents
:
|
11272275 - Increase of ccr1 and ccr5 expression and enhanced functional response to mip-1 alpha du... 21681945 - Endotoxin contamination delays the foreign body reaction. 14713335 - Truncated thioredoxin: physiological functions and mechanism. 19332545 - Abscisic acid released by human monocytes activates monocytes and vascular smooth muscl... 15209105 - The evolution of resistance through costly acquired immunity. 11502985 - Biphasic response of the regional lymphatics in the normal lymphocyte transfer reaction. |
Publication Detail:
|
Type: In Vitro; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Arthritis and rheumatism Volume: 46 ISSN: 0004-3591 ISO Abbreviation: Arthritis Rheum. Publication Date: 2002 Oct |
Date Detail:
|
Created Date: 2002-10-17 Completed Date: 2002-11-14 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370605 Medline TA: Arthritis Rheum Country: United States |
Other Details:
|
Languages: eng Pagination: 2578-86 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medicine and Clinical Science, Graduate School of Medicine and Dentistry, Okayama University, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Antigens, CD14 / analysis*, blood Arthritis, Rheumatoid / immunology* Cell Differentiation / drug effects Cells, Cultured Female Humans Intercellular Adhesion Molecule-1 / analysis, biosynthesis Interleukin-10 / blood, pharmacology Joints / immunology Leukocyte Count Macrophage Colony-Stimulating Factor / blood, pharmacology Macrophages / immunology Male Middle Aged Monocytes / chemistry*, cytology, metabolism Receptors, CCR1 Receptors, CCR5 / analysis, biosynthesis Receptors, Chemokine / analysis, biosynthesis Receptors, IgG / analysis* Solubility Transforming Growth Factor beta / blood, pharmacology Transforming Growth Factor beta1 |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, CD14; 0/CCR1 protein, human; 0/Receptors, CCR1; 0/Receptors, CCR5; 0/Receptors, Chemokine; 0/Receptors, IgG; 0/TGFB1 protein, human; 0/Transforming Growth Factor beta; 0/Transforming Growth Factor beta1; 126547-89-5/Intercellular Adhesion Molecule-1; 130068-27-8/Interleukin-10; 81627-83-0/Macrophage Colony-Stimulating Factor |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion.
Next Document: Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth...